Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04803877
Title SARC038: Phase 2 Study of Regorafenib and Nivolumab in Osteosarcoma
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Sarcoma Alliance for Research through Collaboration
Indications

osteosarcoma

Therapies

Nivolumab + Regorafenib

Age Groups: adult | senior | child
Covered Countries USA


No variant requirements are available.